title: [Radiation induced skin reactions].
abstract: Radiotherapy is one of the most important treatment modality of cancers. Skin secondary effects are well known. Cutaneous complications are described. Physiopathogenic mechanisms are reported. Many preventative and treatment options have been used with varying degrees of evidence of success. Information of patients, further research studies and a multidisciplinary approach are necessary to increase the management of radiation induced skin reactions.
authors.affiliation: Services de Radiothérapie, Hôpital Universitaire Dupuytren, 87042 Limoges cedex. pierre.clavere@orange.fr
authors.forename: P
authors.initials: P
authors.lastname: Clavère
authors.forename: A
authors.initials: A
authors.lastname: Bonnafoux-Clavère
authors.forename: J-M
authors.initials: JM
authors.lastname: Bonnetblanc
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000367:Age Factors; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use; D010431:Pentoxifylline / Q000627:therapeutic use; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D011855:Radiodermatitis / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy; D012307:Risk Factors; D013392:Sucralfate / Q000627:therapeutic use; D013997:Time Factors; D014810:Vitamin E / Q000627:therapeutic use
chemical_list: D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D000897:Anti-Ulcer Agents; D011837:Radiation-Protective Agents; D014810:Vitamin E; D013392:Sucralfate; D006820:Hyaluronic Acid; D010431:Pentoxifylline